Bias in Benefit-Risk Appraisal in Older Products
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 32 (4), 283-291
- https://doi.org/10.2165/00002018-200932040-00003
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Letter by De Backer et al Regarding Article, “Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease: A Randomized, Placebo-Controlled, 4-Year Study”Circulation, 2008
- Buflomedil in Peripheral Arterial DiseaseCirculation, 2008
- 10th Annual meeting of French Society of Pharmacology, 73rd Annual meeting of Society of Physiology, 27th pharmacovigilance meeting, 54th APNET Seminar and 4th CHU CIC meeting (Corum Montpellier 10‐12 April 2006)Fundamental & Clinical Pharmacology, 2006
- Testing and Implementing Signal Impact Analysis in a Regulatory SettingDrug Safety, 2005
- Impact Analysis of Signals Detected from Spontaneous Adverse Drug Reaction Reporting DataDrug Safety, 2005
- Causal or Casual?Drug Safety, 1997
- A meta‐analysis of randomized, double‐blind, placebo‐controlled studies of the effect of buflomedil on intermittent claudicationFundamental & Clinical Pharmacology, 1995
- Acute buflomedil intoxication: A critically life-threatening conditionIntensive Care Medicine, 1995
- Acute buflomedil intoxication: A life-threatening conditionIntensive Care Medicine, 1994
- Harmonisation in PharmacovigilanceDrug Safety, 1994